Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Logothetis

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Cell Reports|February 21, 2019
Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder CarcinogenesisTadeusz Majewski, Hui Yao, Jolanta Bondaruk, et al.
JNCI Cancer Spectrum|May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With DocetaxelSusan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Journal of Neurosurgery. Spine|June 14, 2024
Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approachThomas H Beckham, Michael K Rooney, Gizem Cifter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2020
A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate CancerPaul G Corn, Miao Zhang, Graciela M Nogueras-Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2018
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With DocetaxelSusan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Iscience|July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerSusan Halabi, Qian Yang, Akash Roy, et al.
Iscience|June 24, 2022
The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trialDavid C Smith, Matthew R Smith, Christopher Sweeney, et al.
Cancers|July 9, 2022
Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) ComponentsRama Soundararajan, Paul Viscuse, Patrick Pilie, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Cell Reports|February 21, 2019
Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder CarcinogenesisTadeusz Majewski, Hui Yao, Jolanta Bondaruk, et al.
JNCI Cancer Spectrum|May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With DocetaxelSusan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Journal of Neurosurgery. Spine|June 14, 2024
Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approachThomas H Beckham, Michael K Rooney, Gizem Cifter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2020
A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate CancerPaul G Corn, Miao Zhang, Graciela M Nogueras-Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2018
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With DocetaxelSusan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Iscience|July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerSusan Halabi, Qian Yang, Akash Roy, et al.
Iscience|June 24, 2022
The origin of bladder cancer from mucosal field effectsJolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trialDavid C Smith, Matthew R Smith, Christopher Sweeney, et al.
Cancers|July 9, 2022
Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) ComponentsRama Soundararajan, Paul Viscuse, Patrick Pilie, et al.
Pageof 9